Latest News
Article on Synbody Biotechnology in BioCentury BioBusiness

Synbody: Tackling Tough Targets :Article on Synbody Technology in BioCentury BioBusiness

September 25, 2012


Synbody Commences Operations in CT

March 17 2012 - Synbody Biotechnology, Inc. announces $750K in seed investment from Connecticut Innovations and commences operations to develop Synbody technology for human therapeutics and diagnostics in Farmington, CT.

September 25, 2012


Breakthrough Technology
Synbodies: controlled engineering of fully synthetic, high affinity, high specificity ligands for therapeutic, diagnostic, bioseparation and research applications
Therapies
Synbodies revolutionize the field of high affinity, high specificity therapeutic agents by creating antibody-
Meet With Synbody
Synbody will be attending upcoming meetings. Contact us today to learn more about therapeutic and non-therapeutic Synbody development